Elisa Sasse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elisa Sasse has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Albertina M Carvalho
Oncology Center (Centro Oncologico), Luanda, Angola
1 shared publication - Andre Deeke Sasse
ORCID http://orcid.org
1 shared publication Daniel de Souza e Silva
Believe Neurophysiology Clinic, Rio de Janeiro, Brazil
1 shared publication- João Santos Pereira
Universidade do Estado do Rio de Janeiro
1 shared publication - Ligia Traldi Macedo
University of Campinas, School of Medical Sciences, Department of Anesthesiology, Oncology, and Radiology, Clinical Oncology Service, Campinas, SP, Brazil; University of Campinas, School of Medical Sciences, Department of Internal Medicine, Campinas, SP, Brazil
1 shared publication Luiz Felipe Rocha Vasconcellos
Neurology Service, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil
1 shared publication
Latest Publications
- 1 December 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 371, 15-16
Chewing-induced blepharospasm in Parkinson's disease
- 1 December 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 371, 15-16
Chewing-induced blepharospasm in Parkinson's disease
- Open Access
- 2 February 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 54
Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review
Locally advanced prostate cancer is often associated with elevated recurrence rates. Despite the modest response observed, external-beam radiotherapy has been the preferred treatment for this condition. More recent evidence from randomised trials has demonstrated clinical benefit with the combined use of androgen suppression in such cases. The aim of this meta-analysis is to compare the combination of distinct hormone therapy modalities versus radiotherapy alone for overall survival, disease-free survival and toxicity.
- 2 February 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 54
Open AccessAndrogenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review
Locally advanced prostate cancer is often associated with elevated recurrence rates. Despite the modest response observed, external-beam radiotherapy has been the preferred treatment for this condition. More recent evidence from randomised trials has demonstrated clinical benefit with the combined use of androgen suppression in such cases. The aim of this meta-analysis is to compare the combination of distinct hormone therapy modalities versus radiotherapy alone for overall survival, disease-free survival and toxicity.